Stay updated on CC-97540 in Severe SLE Clinical Trial
Sign up to get notified when there's something new on the CC-97540 in Severe SLE Clinical Trial page.

Latest updates to the CC-97540 in Severe SLE Clinical Trial page
- Check4 days agoChange DetectedNo significant changes detected between the old and new screenshots; observed differences are minor UI/layout updates and non-substantive wording. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoChange DetectedAdded an estimated Last Update Posted timestamp and a new Revision label (v3.3.2) to the study page. The previous Last Update Posted entry and the older revision label (v3.2.0) were removed.SummaryDifference0.1%

- Check18 days agoChange DetectedNew recruitment site Local Institution - 0028 was added. The inclusion criteria were updated to require inadequate response to ≥3 immunosuppressive therapies (IST); the last update posted is 2025-11.SummaryDifference0.6%

- Check25 days agoChange DetectedNo significant additions or deletions were detected; the page content and structure appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedMinor formatting and layout adjustments on the Study Details page for NCT05869955; core study information (title, conditions, eligibility, endpoints, and recruitment status) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe inclusion criterion was updated to require inadequate response to three or more immunosuppressive therapies (IST), replacing the prior condition of inadequate response to at least one of several listed therapies for at least 3 months.SummaryDifference0.4%

Stay in the know with updates to CC-97540 in Severe SLE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-97540 in Severe SLE Clinical Trial page.